Sophie Kurk

4PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 14, 2021
Worse capecitabine treatment outcome in patients with a low skeletal muscle mass is not explained by altered pharmacokinetics.

Laura Molenaar-Kuijsten, Bart Albertus Wilhelmus Jacobs, Sophie Alberdine Kurk

|May 17, 2019
Skeletal muscle mass loss and dose-limiting toxicities in metastatic colorectal cancer patients.

Sophie Kurk, Petra Peeters, Rebecca Stellato

|Aug 26, 2018
Impact of different palliative systemic treatments on skeletal muscle mass in metastatic colorectal cancer patients.

Sophie A Kurk, Petra H M Peeters, Bram Dorresteijn

Pageof 1

Frequent Collaborators